About ADRO

Aduro Biotech, Inc. is a clinical-stage immuno-oncology company focused on the development of technology platforms to stimulate an immune response against cancer. Aduros lead platform is based on proprietary strains of live-attenuated, double-deleted (LADD) Listeria monocytogenes that induce a potent innate immune response and have been engineered to express tumor-associated antigens to induce tumor-specific T cell-mediated immunity. Aduro has received Breakthrough Therapy designation from the FDA for its lead LADD regimen, CRS-207 in combination with GVAX Pancreas in pancreatic cancer. The company is evaluating the proprietary immuno-oncology combination in the ongoing Phase 2b ECLIPSE clinical trial and has additional ongoing clinical trials with its LADD platform in mesothelioma and glioblastoma. The company is also developing clinical candidates using cyclic dinucleotide (CDN) synthetic small molecule immune modulators that are designed to activate the intracellular STING receptor, a central mediator of the innate immune response.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ADRO is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
PRFZ Invesco FTSE RAFI US 1500 Small-Mid ETF 2.0 B 1.9571E+09 1,485 1485 0.01% 0.0001 195 K 195007
IBB iShares Nasdaq Biotechnology Index Fund 7.3 B 7.34933E+09 222 222 0.04% 0.0004 2.7 M 2674950
ITOT iShares Core S&P Total U.S. Stock Market ETF 19.5 B 1.95299E+10 3,547 3547 0.0% 0 57 K 56734
IWM iShares Russell 2000 ETF 40.5 B 4.05202E+10 1,989 1989 0.01% 0.0001 4.2 M 4224380
IWO iShares Russell 2000 Growth ETF 8.8 B 8.79796E+09 1,232 1232 0.02% 0.0002 1.8 M 1785720
IWV iShares Russell 3000 ETF 9.1 B 9.10141E+09 2,929 2929 0.0% 0 75 K 74608
FHLC Fidelity MSCI Health Care Index ETF 1.5 B 1.5E+09 356 356 0.0% 3.16751E-05 48 K 48118
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 2.1 B 2.1E+09 1,002 1002 0.0% 2.70828E-05 58 K 57569
BIB ProShares Ultra Nasdaq Biotechnology 223.8 M 2.2382E+08 239 239 0.02% 0.000152585 72 K 71517
UBIO Proshares UltraPro Nasdaq Biotechnology 28.3 M 2.82606E+07 228 228 0.01% 0.00010075 9 K 8861
URTY ProShares UltraPro Russell2000 85.2 M 8.5176E+07 2,005 2005 0.0% 2.58942E-05 7 K 7071
UWM ProShares Ultra Russell2000 181.5 M 1.8146E+08 2,006 2006 0.0% 3.55869E-05 14 K 14450